# A Trial Investigating the Accuracy of Continuous Glucose Monitor Systems ("Supersapiens" Abbott Libre Sense and Dexcom G6) During Exercise in People With Normal Glucose Tolerance

> **NCT06034574** · — · UNKNOWN · sponsor: **Imperial College London** · enrollment: 24 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Continuous glucose monitoring

## Key facts

- **NCT ID:** NCT06034574
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06034574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06034574, "A Trial Investigating the Accuracy of Continuous Glucose Monitor Systems ("Supersapiens" Abbott Libre Sense and Dexcom G6) During Exercise in People With Normal Glucose Tolerance". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06034574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*